… We are uncertain whether hyperimmune immunoglobulin is an effective treatment for
people hospitalised with COVID‐19, and whether it affects the number of unwanted or serious …

… anti-SARS-CoV-2 antibodies at the time of treatment, but did … Hyperimmune intravenous
immunoglobulin (hIVIG) is derived from healthy individuals who have recovered from COVID-19 …

… may be found in both CP and hyperimmune globulins. To give a … on CP and HIG therapies
used in COVID-19 disease. … For example, neutralizing antibodies to an infectious agent may …

… The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment
of severe acute respiratory infections of viral etiology: a systematic review and exploratory …

… high levels of polyclonal antibodies of different subclasses … both hospitalized and ambulatory
COVID-19 patients, whose main … -SARS-CoV-2 hyperimmune polyclonal immunoglobulins. …

… treat COVID-19. This wealth of information thus indicates that CPT or hyperimmune
immunoglobulins can be proven as a boon in the future for the management of COVID-19 and needs …

… of producing hyperimmune anti-COVID-19 intravenously administrable immunoglobulin (C-…
effective passive immunization treatment option for COVID-19. Materials & methods: PCP …

… particular focus to hyperimmune IVIG for COVID-19 has not … , randomized study of severe
and critical COVID-19 patients. … of hyperimmune anti COVID-19 Intravenous Immunoglobulin (…

… Secondary objectives comprised of various efficacy parameters, neutralizing antibodies, and
safety with COVID-19 HIG plus standard of care versus only standard of care in participants …

… of hyperimmune serum versus CCP and mAb, and summarize the ongoing clinical trials of
COVID-19 hyperimmune … review the ongoing clinical trials of COVID-19 hyperimmune serum. …